PRODUCT LIST - JULY 2019

RESPIRATORY
API (s) FORM STRENGTH PACK EU DOSSIER
TIOTROPIUM INH. POWDER 18 MCG x30 DOSES Under Development
(100+6) MCG x120 DOSES
BUDESONIDE + FORMOTEROL INH. POWDER (200+6) MCG x120 DOSES
(400+12) MCG x 60 DOSES
250 MCG
FLUTICASONE INH. POWDER x60 DOSES
500 MCG
(100+50) MCG
FLUTICASONE + SALMETEROL INH. POWDER (250+50) MCG x60 DOSES
(500+50) MCG

CENTRAL NERVOUS SYSTEM

API (s) FORM STRENGTH PACK EU DOSSIER
25 MG
50 MG
75 MG
PREGABALIN CAPS 100 MG x14 CAPS
150 MG
200 MG
300 MG

CARDIOMETABOLICS
API (s) FORM STRENGTH PACK EU DOSSIER
VILDAGLIPTIN TABS 50 MG x28 TABS Under Development
(50+850) MG
VILDAGLIPTIN + METFORMIN F/C TABS x56 TABS Under Development
(50+1000) MG
(10+10) MG
(20+10) MG
ATORVASTATIN + EZETIMIBE F/C TABS x30 TABS Under Development
(40+10) MG
(80+10) MG
(5+10) MG
(10+10) MG
ROSUVASTATIN + EZETIMIBE F/C TABS x30 TABS
(20+10) MG
(40+10) MG

CARDIOVASCULAR
API (s) FORM STRENGTH PACK EU DOSSIER
375 MG
RANOLAZINE XR TABS 500 MG x60 TABS Under Development
750 MG
60 MG
TICAGRELOR F/C TABS x56 TABS Under Development
90 MG
2,5 MG x56 TABS
10 MG x10 TABS
RIVAROXABAN F/C TABS
15 MG x30 TABS
20 MG x30 TABS
(5+75) MG
(5+150) MG
AMLODIPINE + IRBESARTAN F/C TABS (10+150) MG x30 TABS
(5+300) MG
(10+300) MG

Disclaimer: The information contained in this document is solely for informational purposes and does not constitute an offer in any sense. There are no express or implied warranties of
merchantability and fitness for a particular purpose or that the use of the information and/or products will not infringe any proprietary rights of any third party. Products protected by valid patents
are not available for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility to check the patent situation of the product in the market
of interest.
CARDIOVASCULAR (cont)
(5+80) MG
AMLODIPINE + VALSARTAN F/C TABS (5+160) MG x28 TABS
(10+160) MG
(5+160+12,5) MG
(5+160+25) MG
AMLODIPINE + VALSARTAN + HCTZ F/C TABS (10+160+12.5) MG x28 TABS
(10+160+25) MG
(10+320+25) MG
CILOSTAZOL TABS 100 MG x28 TABS
75 MG
IRBESARTAN F/C TABS 150 MG x28 TABS
300 MG
5 MG
10 MG
ROSUVASTATIN F/C TABS x28 TABS
20 MG
40 MG

ANTIMICROBIALS
API (s) FORM STRENGTH PACK EU DOSSIER
125 MG/5 ML
CLARITHROMYCIN GRAN ORAL SUSP. FL x 60ML Under Development
250 MG/5 ML
VORICONAZOLE LYOPH PS INJ 200 MG x1 VIAL
AMOXICILLIN + CLAVULANIC PD. ORAL SUSP. (875+125) MG x12 SACHETS

VARIOUS
API (s) FORM STRENGTH PACK EU DOSSIER
ESOMEPRAZOLE LYOPH PS INJ 40 MG/VIAL x1 VIAL
OMEPRAZOLE LYOPH PS INJ 40 MG/VIAL + 10 ML SOLV x 1 VIAL + SOLV

OTC SKIN CARE

DESCRIPTION FORM REG. STATUS SIZE PRODUCT AVAILABILITY
RADIATION DERMATITIS CREAM CE MEDICAL DEVICE 100 ML
SHOWER GEL FOR SENSITIVE SKIN LIQUID COSMETIC 150 ML
SKIN RELIEF CREAM CE MEDICAL DEVICE 100 ML

GASTROINTESTINALS
DESCRIPTION FORM REG. STATUS SIZE ESTIMATED LAUNCH TIME
ELECTROLYTES POWDER ORAL SOLUTION FOOD SUPPLEMENT x12 SACHETS
ELECTROLYTES EFFERVESCENT FOOD SUPPLEMENT x15 EFF. TABS
ELECTROLYTES FOR ATHLETES* EFFERVESCENT FOOD SUPPLEMENT x20 EFF. TABS
*The product is not available for Benelux, DACH (Germany/Austria/Switzerland), UK, Scandinavia, France, Spain, Portugal and Italy.

Disclaimer: The information contained in this document is solely for informational purposes and does not constitute an offer in any sense. There are no express or implied warranties of
merchantability and fitness for a particular purpose or that the use of the information and/or products will not infringe any proprietary rights of any third party. Products protected by valid patents
are not available for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility to check the patent situation of the product in the market
of interest.